A new drug reduced the risk of relapse and increased survival by five months, according to a recent study. The results were presented at a cancer conference in Chicago in June. Most often found in bone marrow sites, multiple myeloma is considered a chronic disease, although several new treatment options have increased the survival rate...Continue Reading